Biological Drug Targets

The term biological target is additionally utilized as a part of pharmaceutical research to depict the common protein in the body whose action is altered by a drug bringing about an impact at a particular site, which might be a satisfactory helpful impact or an unnecessary adverse effect. Directed drug conveyance frameworks have been produced to improve regenerative strategies. Various types of drug targets are:

  • Nucleic Acids
  • G-protein coupled receptors
  • Liposomes
  • Nanoparticles
  • Epigenetics

Related Conference of Biological Drug Targets

November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
February 24-25, 2025

2nd International Conference on Pharmacognosy

Madrid, Spain
March 10-11, 2025

35th Annual European Pharma Congress

Rome, Italy
March 13-14, 2025

8th International on Pharmacy and Pharmaceutical Conference

Prague, Czech Republic
April 14-15, 2025

18th European Biosimilars Congress

Paris, France
April 24-25, 2025

18th World Drug Delivery Summit

London, UK
May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
July 24-25, 2025

5th World Congress on Cardiovascular Medicine Pharmacology

Aix-en-Provence, France
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
October 22-23, 2025

7th European Conference on Advance Clinical Trials and Research

Aix-en-Provence, France

Biological Drug Targets Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in